Clinical outcomes and quality of life of COVID-19 survivors: a follow-up of 3 months post hospital discharge
| Autor: | Victor L P Amorim, Gabriela Varela, Bruno T. Cabral, Felipe Maia de Toledo Piza, Bruna A Campos, Beatriz Costa Todt, Leonardo E. Polesso, Ingra N.S. Bordon, Cristina M B Fonseca, Diogo Kogiso, Luiza Helena Degani-Costa, Alana O.M. Linhares, Claudia Szlejf, Etienne Duim |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Pulmonary and Respiratory Medicine
Male Pediatrics medicine.medical_specialty Time Factors Anxiety Cohort Studies 03 medical and health sciences 0302 clinical medicine Sex Factors Quality of life Surveys and Questionnaires medicine Hospital discharge Humans 030212 general & internal medicine Survivors Critical Care Outcomes Depression (differential diagnoses) Original Research Depression business.industry Medical record COVID-19 Emergency department Middle Aged Mental health Patient Discharge critical care Mental Health 030228 respiratory system Quality of Life Female medicine.symptom business Brazil Follow-Up Studies Cohort study |
| Zdroj: | Respiratory Medicine |
| DOI: | 10.1183/13993003.congress-2021.pa607 |
| Popis: | Background Over 66 million people worldwide have been diagnosed with COVID-19. Therefore, understanding their clinical evolution beyond hospital discharge is essential not only from an individual standpoint, but from a populational level. Objectives Our primary aim was to assess the impact of COVID-19 on health-related quality of life (HRQoL) 3 months after hospital discharge. Additionally, we screened for anxiety and depression and assessed important clinical outcomes. Methods This was a single-centre cohort study performed in Sao Paulo (Brazil), in which participants were contacted by telephone to answer a short survey. EQ-5D-3L was used to assess HRQoL and clinical data from patients’ index admission were retrieved from medical records. Results We contacted 251 participants (59.8% males, mean age 53 years old), 69.7% of which had presented with severe COVID-19. At 3 months of follow-up, 6 patients had died, 51 (20.3%) had visited the emergency department again and 17 (6.8%) had been readmitted to hospital. Seventy patients (27.9%) persisted with increased dyspnoea and 81 had a positive screening for anxiety/depression. Similarly, patients reported an overall worsening of EQ-5D-3L single summary index at 3 months compared to before the onset of COVID-19 symptoms (0.8012 (0.7368 – 1.0) vs. 1.0(0.7368 – 1.0), p |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|